Response to C-CAR088 T cell therapy in response-evaluable population
| Best overall response, n (%) | Low-dose group | Medium-dose group | High-dose group | Total |
| Response-evaluable population | n=3 | n=11 | n=14 | n=28 |
| ORR | 3 (100.0) | 11 (100) | 13 (92.9) | 27 (96.4) |
| sCR | 0 (0.0) | 5 (45.5) | 8 (57.1) | 13 (46.4) |
| CR | 0 (0.0) | 1 (9.1) | 2 (14.3) | 3 (10.7) |
| VGPR | 3 (100.0) | 4 (36.4) | 2 (14.3) | 9 (32.1) |
| PR | 0 (0.0) | 1 (9.1) | 1 (7.1) | 2 (7.1) |
| SD | 0 (0.0) | 0 (0.0) | 1 (7.1) | 1 (3.6) |
CR, complete response; ORR, overall response rate; PR, partial response; sCR, stringent complete response; SD, stable disease; VGPR, very good partial response.